Skip to main navigation Skip to search Skip to main content

Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study

  • Colin Sauder
  • , Luke A. Allen
  • , Elizabeth Baker
  • , Andrew C. Miller
  • , Steven M. Paul
  • , Stephen K. Brannan

Research output: Contribution to journal › Article › peer-review

85   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

Psychology